PVRL2 Suppresses Antitumor Immunity through PVRIG- and TIGIT-independent Pathways.
Yang J, Wang L, Byrnes JR, Kirkemo LL, Driks H, Belair CD, Aguilar OA, Lanier LL, Wells JA, Fong L, Blelloch R.
Yang J, et al. Among authors: blelloch r.
Cancer Immunol Res. 2024 May 2;12(5):575-591. doi: 10.1158/2326-6066.CIR-23-0722.
Cancer Immunol Res. 2024.
PMID: 38588410
Free PMC article.